Page 10 of 19 – SEC Filing CUSIP No. 09058V103 Page 10 of 15
Introductory Note: This Schedule 13G is filed on behalf of Venrock Healthcare Capital Partners, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP I”), VHCP Co-Investment Holdings, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Invest I”), Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP II”), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Invest II”), VHCP Management, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management”), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management II” and collectively with VHCP I, VHCP Co-Invest I, VHCP II, VHCP Co-Investment II, and VHCP Management, the “Venrock Entities”), Anders Hove (“Hove”) and Bong Koh (“Koh”) in respect of Common Stock of BioCryst Pharmaceuticals, Inc. Item 1.
(a) Name of Issuer
BioCryst Pharmaceuticals, Inc. (b) Address of Issuer’s Principal Executive Offices
4505 Emperor Boulevard, Suite 200 Durham, NC 27703 Item 2.
(a) Name of Person Filing Venrock Healthcare Capital Partners, L.P. VHCP Co-Investment Holdings, LLC Venrock Healthcare Capital Partners II, L.P. VHCP Co-Investment Holdings II, LLC VHCP Management, LLC VHCP Management II, LLC Anders Hove Bong Koh
(b) Address of Principal Business Office or, if none, Residence
New York Office: Palo Alto Office: Boston Office: 530 Fifth Avenue 3340 Hillview Avenue 470 Atlantic Avenue 22nd Floor Palo Alto, CA 94304 4th Floor New York, NY 10036 Boston, MA 02210
(c) Citizenship
All entities were organized in Delaware. The individuals are both United States citizens. Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP No. 09058V103 | Page 10 of 15 |
Introductory Note: This Schedule 13G is filed on behalf of Venrock Healthcare Capital Partners, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP I”), VHCP Co-Investment Holdings, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Invest I”), Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP II”), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Invest II”), VHCP Management, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management”), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management II” and collectively with VHCP I, VHCP Co-Invest I, VHCP II, VHCP Co-Investment II, and VHCP Management, the “Venrock Entities”), Anders Hove (“Hove”) and Bong Koh (“Koh”) in respect of Common Stock of BioCryst Pharmaceuticals, Inc.
| Item 1. |
| (a) | Name of Issuer |
BioCryst Pharmaceuticals, Inc.
| (b) | Address of Issuer’s Principal Executive Offices |
4505 Emperor Boulevard, Suite 200
Durham, NC 27703
| Item 2. |
| (a) | Name of Person Filing | |
| Venrock Healthcare Capital Partners, L.P. | ||
| VHCP Co-Investment Holdings, LLC | ||
| Venrock Healthcare Capital Partners II, L.P. | ||
| VHCP Co-Investment Holdings II, LLC | ||
| VHCP Management, LLC | ||
| VHCP Management II, LLC | ||
| Anders Hove | ||
| Bong Koh |
| (b) | Address of Principal Business Office or, if none, Residence |
| New York Office: | | Palo Alto Office: | | Boston Office: |
| 530 Fifth Avenue | | 3340 Hillview Avenue | | 470 Atlantic Avenue |
| 22nd Floor | | Palo Alto, CA 94304 | | 4th Floor |
| New York, NY 10036 | | | Boston, MA 02210 |
| (c) | Citizenship |
All entities were organized in Delaware. The individuals are both United States citizens.
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
